Loading…
Milestone Pharmaceuticals Inc. is projected to rise to $1.63 by 2027, a +16% move from its current price of $1.40. MIST is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.34 | $1.40 | $1.46 | +0.10% |
| May 30 | $1.32 | $1.40 | $1.49 | +0.21% |
| May 31 | $1.31 | $1.40 | $1.51 | +0.31% |
| Jun 1 | $1.29 | $1.41 | $1.53 | +0.41% |
| Jun 2 | $1.28 | $1.41 | $1.54 | +0.52% |
| Jun 3 | $1.27 | $1.41 | $1.56 | +0.62% |
| Jun 4 | $1.26 | $1.41 | $1.57 | +0.72% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.26 | $1.41 | $1.57 | +0.72% |
| Week 2 | $1.22 | $1.42 | $1.66 | +1.45% |
| Week 3 | $1.18 | $1.43 | $1.73 | +2.19% |
| Week 4 | $1.16 | $1.44 | $1.79 | +2.93% |
| Week 5 | $1.14 | $1.45 | $1.85 | +3.67% |
| Week 6 | $1.12 | $1.46 | $1.91 | +4.42% |
| Week 7 | $1.10 | $1.47 | $1.97 | +5.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR).
It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc. was incorporated in 2003 and is headquartered in Montreal, Canada.
Milestone Pharmaceuticals Inc. (MIST) is the company behind CARDAMYST, a nasal spray designed to treat acute PSVT episodes and restore sinus rhythm in adults. The current price is $1.41 with a market cap of $175.54M and a market position of rank 3917.
The forecast suggests the average price could rise from $1.41 in 2026 toward higher levels, with 2030 at $2.02 on average and longer-term averages of $4.68 by 2040 and $10.56 by 2050.
A major floor 38.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 57.1% above — a clean break opens room to run.
A major ceiling 76.2% above — clearing it would confirm fresh momentum.
Key MIST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MIST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.45 | Sell | $1.44 | Sell |
| MA 10 | $1.50 | Sell | $1.52 | Sell |
| MA 20 | $1.69 | Sell | $1.62 | Sell |
| MA 50 | $1.68 | Sell | $1.71 | Sell |
| MA 100 | $1.76 | Sell | $1.77 | Sell |
| MA 200 | $1.90 | Sell | $1.81 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.04 | Neutral |
| Stoch RSI (14) | 7.42 | Buy |
| CCI (20) | -98.78 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -27.08 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.48 | Sell |
| Awesome (5,34) | -0.37 | Sell |
| Ultimate (7,14,28) | 26.22 | Buy |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 1.40 | Buy |
| ADX (14) | 22.51 | Sell |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 30. The stock trades below the 50-day and 200-day moving averages, which are $1.69 and $1.90 respectively. The price sits at the $1.41 support level, while resistance is seen at $2.20. The 30-day price range spans from $1.06 to $1.88.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.01 | $1.40 | $2.04 | 0% | Neutral | |
| $1.23 | $1.63 | $2.32 | +16% | Neutral | |
| $1.31 | $1.82 | $2.72 | +30% | Bullish | |
| $1.15 | $1.65 | $2.57 | +18% | Neutral | |
| $1.31 | $1.94 | $3.13 | +39% | Bullish | |
| $1.70 | $2.60 | $4.32 | +86% | Bullish | |
| $1.74 | $2.75 | $4.67 | +96% | Bullish | |
| $1.89 | $3.07 | $5.33 | +119% | Bullish | |
| $1.72 | $2.86 | $5.08 | +104% | Bullish | |
| $1.55 | $2.65 | $4.79 | +89% | Bullish | |
| $2.30 | $4.43 | $8.69 | +216% | Bullish | |
| $4.35 | $9.67 | $21.29 | +591% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.01 | $1.40 | $1.66 | +0.00% |
| June 2026 | $1.25 | $1.49 | $1.82 | +6.39% |
| July 2026 | $1.28 | $1.54 | $1.92 | +3.25% |
| August 2026 | $1.24 | $1.51 | $1.91 | -1.92% |
| September 2026 | $1.25 | $1.54 | $1.97 | +1.88% |
| October 2026 | $1.30 | $1.60 | $2.08 | +4.30% |
| November 2026 | $1.27 | $1.58 | $2.07 | -1.56% |
| December 2026 | $1.23 | $1.54 | $2.04 | -2.41% |
Click any year to see its month-by-month MIST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MIST could reach as high as $2.04, with a base case around $1.40 and support toward $1.01 — roughly 0% from $1.40. Price action looks broadly range-bound.
Expect MIST to range from $1.23 to $2.32 through 2027. The $1.63 average target implies a +16% move from current prices. That is up +16% on the projected 2026 average. A consolidation phase looks the most probable path here.
The MIST price prediction for 2028 points to an average of $1.82 (low $1.31, high $2.72) — a potential gain of +30% on today's $1.40. Momentum favours further upside here.
In 2029, MIST is projected to trade between $1.15 and $2.57, averaging $1.65 — a potential gain of +18% from today's $1.40. That is -9% versus the projected 2028 average. A consolidation phase looks the most probable path here.
Milestone Pharmaceuticals Inc.'s 2030 outlook centres on $1.94, within a $1.31 to $3.13 range. That is up +18% on the projected 2029 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2031, MIST could reach as high as $4.32, with a base case around $2.60 and support toward $1.70 — roughly +86% from $1.40. Buyers look set to stay in control over this stretch.
Expect MIST to range from $1.74 to $4.67 through 2032. The $2.75 average target implies a +96% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The MIST price prediction for 2033 points to an average of $3.07 (low $1.89, high $5.33) — a potential gain of +119% on today's $1.40. Buyers look set to stay in control over this stretch.
In 2034, MIST is projected to trade between $1.72 and $5.08, averaging $2.86 — a potential gain of +104% from today's $1.40. That is -7% versus the projected 2033 average. Momentum favours further upside here.
Milestone Pharmaceuticals Inc.'s 2035 outlook centres on $2.65, within a $1.55 to $4.79 range. That is -7% versus the projected 2034 average. That marks a +89% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MIST could reach as high as $8.69, with a base case around $4.43 and support toward $2.30 — roughly +216% from $1.40. Momentum favours further upside here.
Expect MIST to range from $4.35 to $21.29 through 2050. The $9.67 average target implies a +591% move from current prices. That is up +118% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MIST today (≈ 714.285714 MIST) could be worth
$6,905.53
+$5,905.53 (+591%) by 2050 · US Dollar
Based on the average projected MIST price of $9.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MISTwould be worth at today's price.
$1,000 invested in MIST on May 27, 2025 (≈ 704.225373 MIST) would be worth
$985.92
-$14.08 (-1.4%) today · 0.99× · US Dollar
Based on a MIST entry price of $1.42 vs. today's $1.4.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.5 | $933.33 | -6.7% |
| 1 month ago | $1.86 | $752.69 | -24.7% |
| 3 months ago | $1.72 | $813.95 | -18.6% |
| 6 months ago | $2.69 | $520.45 | -48.0% |
| 1 year ago | $1.42 | $985.92 | -1.4% |
| All time (5.0y) ago | $5.83 | $240.14 | -76.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MIST forecast.
Our base-case forecast reaches $2.80 around 2033.
Implied market cap at $2.80: $348.59M
The multi-year forecast shows persistent upside, with 2027 avg $1.66 and 2028 avg $1.84, rising further in 2030 to an average of $2.02 and a 43.6 ROI. The 2031–2035 period continues the bullish trajectory, with 2031 avg $2.74 (94.4 ROI), 2032 avg $2.90 (105.6 ROI), 2033 avg $3.24 (129.5 ROI), 2034 avg $2.97 (110.5 ROI), and 2035 avg $2.77 (96.5 ROI). By 2040 the average price is projected at $4.68 with a 231.8 ROI, and by 2050 the average reaches $10.56 with a 648.8 ROI.
These are estimates and not guarantees; uncertainty remains in any long-range projection.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $2.02 with a min of $1.34 and a max of $3.32; ROI: 43.6; sentiment: BULLISH.
The near-term sentiment is BEARISH (RSI 30, price near $1.41 with support at $1.41 and resistance at $2.20). The 2026 forecast is NEUTRAL, while later years show bullish potential, including 2030–2050 averages and returns; these are estimates, not guarantees.
Yes. The forecast shows a max of $5.75 in 2033 and a max of $5.03 in 2032, with 2033 averaging $3.24 and ROI 129.5, suggesting the possibility of crossing $5 in the 2030s.
Current price is $1.41 and market cap is $175.54M; the rank is 3917.
The 2040 forecast shows an average price of $4.68 with a min of $2.32 and a max of $9.42; ROI: 231.8; sentiment: BULLISH.
Milestone Pharmaceuticals Inc. Community Discussion
0Share your Milestone Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.